LO ÚLTIMO DE LO ÚLTIMO EN SÍNDROME DE ABSTINENCIA NEONATAL ► Genomics|Features|Neonatal Abstinence Syndrome [idioma inglés únicamente]

Genomics|Features|Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome: Public Health and Genomic Insights - March 11, 2015

Infant and maternal characteristics in neonatal abstinence syndrome - selected hospitals in Florida, 2010-2011.
Lind Jennifer N et al. MMWR Morb. Mortal. Wkly. Rep.2015 Mar 6. (8) 213-6

Implementation of a statewide surveillance system for neonatal abstinence syndrome - tennessee, 2013.
Warren Michael D et al. MMWR Morb. Mortal. Wkly. Rep.2015 Feb 13. (5) 125-8

Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome.
Elkomy Mh et al. Clin. Pharmacol. Ther. 2015 Feb (2) 167-76

Opioid prescription claims among women of reproductive age--United States, 2008-2012.
Ailes Elizabeth C et al. MMWR Morb. Mortal. Wkly. Rep. 2015 Jan 23. (2) 37-41

Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome.
Wachman Elisha M et al. J. Pediatr. 2014 Sep (3) 472-8

Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome.
Wachman Elisha M et al. JAMA 2013 May 1. (17) 1821-7

Study explores genetic factors in neonatal abstinence syndrome, Contemporary Pediatrics 2013

In-utero methadone or subutex exposure could alter gene expression, cause severe neonatal abstinence syndrome, Boston University, 2014

What is neonatal abstinence syndrome? PubMed Health, National Library of Medicine